Clinical Trials Browser

Phase 2 × Urethral Neoplasms × lonafarnib × Clear all

NCT00006351 2012-09-24

SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract

Phase 2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms